STAINES-UPON-THAMES, United
Kingdom, June 17, 2020
/PRNewswire/ -- Mallinckrodt
plc (NYSE: MNK), a global biopharmaceutical company, will
present on Tuesday, June 23, 2020 at
the BMO Prescriptions for Success Healthcare Conference.
Mark Trudeau, President and Chief
Executive Officer, and Bryan
Reasons, Executive Vice President and Chief Financial
Officer, will represent the company in a fireside chat at
8:00 a.m. Eastern Time. To access the
webcast, please refer to the webcast link posted on our site at:
http://www.mallinckrodt.com/investors. A replay of the
fireside chat will also be available following the meeting.
ABOUT MALLINCKRODT
Mallinckrodt is a global business consisting of
multiple wholly owned subsidiaries that develop, manufacture,
market and distribute specialty pharmaceutical products and
therapies. The company's Specialty Brands reportable segment's
areas of focus include autoimmune and rare diseases in specialty
areas like neurology, rheumatology, nephrology, pulmonology and
ophthalmology; immunotherapy and neonatal respiratory critical care
therapies; analgesics and gastrointestinal products. Its Specialty
Generics reportable segment includes specialty generic drugs and
active pharmaceutical ingredients. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
Mallinckrodt uses its website as a
channel of distribution of important company information, such as
press releases, investor presentations and other financial
information. It also uses its website to expedite public access to
time-critical information regarding the company in advance of or in
lieu of distributing a press release or a filing with the U.S.
Securities and Exchange Commission (SEC) disclosing the same
information. Therefore, investors should look to the Investor
Relations page of the website for important and time-critical
information. Visitors to the website can also register to receive
automatic e-mail and other notifications alerting them when new
information is made available on the Investor Relations page of the
website.
CONTACTS
Investor Relations
Daniel J. Speciale, CPA
Vice President, Investor Relations and IRO
(314) 654-3638
daniel.speciale@mnk.com
Media Inquiries
Ron
Bartlett
H+K Strategies
Senior Vice President
813-545-2399
ron.bartlett@hkstrategies.com
Mallinckrodt, the "M" brand mark and
the Mallinckrodt Pharmaceuticals logo are trademarks of a
Mallinckrodt company. Other brands are
trademarks of a Mallinckrodt company or
their respective owners. © 2020
Mallinckrodt. 06/2020
View original content to download
multimedia:http://www.prnewswire.com/news-releases/mallinckrodt-to-present-at-the-bmo-prescriptions-for-success-healthcare-conference-301078292.html
SOURCE Mallinckrodt plc